Oseltamivir phosphate or known as TAMIFLU® is one of FDA-approved to treat and prevent influenza. Question and Answers regarding oseltamivir phosphate antiviral medication is covered in the following article.
Search results for tamiflu
Oseltamivir for Pregnant Women with Suspected Influenza A (H1N1) Infection
The CDC recommends that pregnant women including with HIV-infection and confirmed, probable, or suspected influenza A (H1N1) are at risk of potentially serious disease due to influenza viruses and need to receive antiviral therapy with Oseltamivir (Tamiflu).
Influenza Antiviral Medication Dosing
Below is a table consist of influenza antiviral medication dosing either Oseltamivir and Zanamivir for Influenza Treatment and Chemoprophylaxis. The table describe the dosing of oseltamivir and zanamivir since Influenza A (H1N1) viruses are sensitive to those medications rather than amantadine and ramantadine.
The Safety of Oseltamivir and Zanamivir for the Treatment and Prevention of Influenza
What you will find in this article are sections discuss about the cause of seasonal influenza, the use of oseltamivir and zanamivir for the treatment of uncomplicated influenza as FDA approval, safety profile of oseltamivir and zanamivir (prophylaxis in adults, treatment in adults and children) including report table of safety outcomes for oral oseltamivir and zanamivir used for treatment and prophylaxis.
